Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Pierre Abastado

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Oncoimmunology|December 18, 2012
Myeloid cells: Prime drivers of tumor progressionBenjamin Toh, Benjamin Toh, Jean-Pierre Abastado, et al.
Cancer Research|May 3, 2012
The next challenge in cancer immunotherapy: controlling T-cell traffic to the tumorJean-Pierre Abastado
Medecine Sciences : M/S|May 8, 2014
[The early steps of the metastatic process]Sandra Hubert, Jean-Pierre Abastado
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
Macrophages and cancerAlessandra Nardin, Jean-Pierre Abastado
Oncoimmunology|June 5, 2013
Immunomodulation of the tumor microenvironment by Toll-like receptor-3 (TLR3) ligandsValerie Chew, Jean-Pierre Abastado
Oncoimmunology|June 28, 2012
How to develop better screens for anti-cancer therapies?Michelle Hong, Jean-Pierre Abastado
Journal of Oncology|August 29, 2012
Immune microenvironment in tumor progression: characteristics and challenges for therapyValerie Chew, Han Chong Toh, Jean-Pierre Abastado
Journal of Virology|December 12, 2001
Cross-presentation of human cytomegalovirus pp65 (UL83) to CD8+ T cells is regulated by virus-induced, soluble-mediator-dependent maturation of dendritic cellsGéraldine Arrode, Claire Boccaccio, Jean-Pierre Abastado, et al.
European Journal of Immunology|February 21, 2003
Naive CD8+ T cell recruitment and proliferation are dependent on stage of dendritic cell maturationAndrew Kaiser, Nadège Bercovici, Jean-Pierre Abastado, et al.
Future Oncology (London, England)|April 22, 2017
The Servier oncology pipeline in 2017Patrick Therasse, Beatrice Perron, Sarah A Novack, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Oncoimmunology|December 18, 2012
Myeloid cells: Prime drivers of tumor progressionBenjamin Toh, Benjamin Toh, Jean-Pierre Abastado, et al.
Cancer Research|May 3, 2012
The next challenge in cancer immunotherapy: controlling T-cell traffic to the tumorJean-Pierre Abastado
Medecine Sciences : M/S|May 8, 2014
[The early steps of the metastatic process]Sandra Hubert, Jean-Pierre Abastado
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
Macrophages and cancerAlessandra Nardin, Jean-Pierre Abastado
Oncoimmunology|June 5, 2013
Immunomodulation of the tumor microenvironment by Toll-like receptor-3 (TLR3) ligandsValerie Chew, Jean-Pierre Abastado
Oncoimmunology|June 28, 2012
How to develop better screens for anti-cancer therapies?Michelle Hong, Jean-Pierre Abastado
Journal of Oncology|August 29, 2012
Immune microenvironment in tumor progression: characteristics and challenges for therapyValerie Chew, Han Chong Toh, Jean-Pierre Abastado
Journal of Virology|December 12, 2001
Cross-presentation of human cytomegalovirus pp65 (UL83) to CD8+ T cells is regulated by virus-induced, soluble-mediator-dependent maturation of dendritic cellsGéraldine Arrode, Claire Boccaccio, Jean-Pierre Abastado, et al.
European Journal of Immunology|February 21, 2003
Naive CD8+ T cell recruitment and proliferation are dependent on stage of dendritic cell maturationAndrew Kaiser, Nadège Bercovici, Jean-Pierre Abastado, et al.
Future Oncology (London, England)|April 22, 2017
The Servier oncology pipeline in 2017Patrick Therasse, Beatrice Perron, Sarah A Novack, et al.
Pageof 6